Poddar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 4.94 M
as on 10-12-2024
- Company Age 45 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.17 Cr
as on 10-12-2024
- Revenue 45.38%
(FY 2023)
- Profit 54.17%
(FY 2023)
- Ebitda 2.52%
(FY 2023)
- Net Worth 0.65%
(FY 2023)
- Total Assets 10.46%
(FY 2023)
About Poddar Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.94 M.
The company currently has active open charges totaling ₹5.17 Cr.
Vinay Jain, Arihant Jain, and Aditya Jain serve as directors at the Company.
- CIN/LLPIN
U24233UP1979PTC004806
- Company No.
004806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1979
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Poddar Pharmaceuticals Private Limited offer?
Poddar Pharmaceuticals Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Micronutrient Fertilizers, Common Disease Medicines, Psoriasis Ointment, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Digestive System Drugs & Medicines, Laxatives, Industrial Chemicals & Supplies, Biocides.
Who are the key members and board of directors at Poddar Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Jain  | Managing Director | 24-Aug-1979 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arihant Jain | Whole-Time Director | 14-Jun-2022 | Current |
| Aditya Jain | Director | 13-Feb-2018 | Current |
Financial Performance of Poddar Pharmaceuticals.
Poddar Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.38% increase. The company also saw a substantial improvement in profitability, with a 54.17% increase in profit. The company's net worth moved up by a moderate rise of 0.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poddar Pharmaceuticals?
In 2023, Poddar Pharmaceuticals had a public holding of 54.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Poddar Healthcare Private LimitedActive 13 years 5 monthsVinay Jain, Arihant Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Oct 2023 | ₹1.50 M | Open |
State Bank Of India Creation Date: 14 Mar 2023 | ₹2.38 Cr | Open |
State Bank Of India Creation Date: 07 Feb 2003 | ₹0.23 M | Open |
How Many Employees Work at Poddar Pharmaceuticals?
Poddar Pharmaceuticals has a workforce of 12 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poddar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poddar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
